This week, five Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Tesla — How Da Ya Like Them Apples?
Tesla's stellar run higher is hated by some, loved by others. In fact, the rise of Tesla reminds me of another love/hate stock, Apple. More
10 Biotechnology Stocks to Sell Now
The ratings of 10 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
7 Semiconductor Stocks to Sell Now
For the current week, the overall ratings of seven Semiconductor stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
4 Stocks With Awful Earnings Momentum — FNBN NAV SGK LGCY
This week, these four stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader. More
10 Best “Strong Buy” Stocks — LAD PCYC LL and more
This week, these ten stocks, all currently earning A's ("strong buy") on Portfolio Grader, have the best year-to-date performance. Since the beginning of the year, the Nasdaq is up 10.9%, the Dow increased 13.2%, and the S&P has increased 12.1%. More
Gold Miners Get Their Second Wind, But …
Why are the mining stocks so much hotter than gold itself, and more important, how much further might gold mining equities climb before topping out? As is always the case, that depends. More
